Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Solana CompanyNASDAQ: HSDT
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $180K rose 48.8% year over year, ahead of the -3.6% change in trailing-twelve-month cost of revenue. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +2.6% a year.
Context
- Cost of revenue amounted to 8.3% of revenue in FY2025, down 103.6 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +48.8% holds above the trailing-twelve-month pace of -3.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 500K USD
- Year-over-year change
- -14.1%
- 4-year CAGR
- +13.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 500K | -14.1% |
| FY2024 | 2024-12-31 | 582K | -0.2% |
| FY2023 | 2023-12-31 | 583K | +25.9% |
| FY2022 | 2022-12-31 | 463K | +55.4% |
| FY2021 | 2021-12-31 | 298K | — |
Cost of Revenue vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 cost of revenue of $559K is the lowest of the 11 companies compared; the peer median is $20.64M.
- Its year-over-year change of -3.6% is the 8th highest of 10, against a peer median of +17.1%.
- Cost of revenue amounts to 5.8% of revenue for HSDT, versus a peer median of 47.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $180.21M | -1.6% | -6.5% | 51.3% | |
| LTM Mar 2026 | $80.87M | +47.8% | +7.1% | 55.8% | |
| LTM Mar 2026 | $69.8M | -5.5% | -9.3% | 59.4% | |
| LTM Mar 2026 | $61.59M | -4.5% | +8.6% | 43.3% | |
| LTM Dec 2025 | $25.81M | +17.4% | +18.6% | 198.2% | |
| LTM Mar 2026 | $15.47M | +12.2% | +11.1% | 21.6% | |
| LTM Mar 2026 | $10.78M | +27.5% | +32.5% | 24.3% | |
| LTM Mar 2026 | $6.7M | +44.8% | +45.6% | 14.9% | |
| LTM Mar 2026 | $5.46M | +17.1% | +9.4% | 28.9% | |
| LTM Mar 2026 | $2.63M | — | — | 426.2% | |
| LTM Mar 2026 | $559K | -3.6% | +2.6% | 5.8% | |
| Peer median (excluding HSDT) | $20.64M | +17.1% | +9.4% | 47.3% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 522K | 787K | 644K | 520K | 6.02M |
| Cost of Revenue | 298K | 463K | 583K | 582K | 500K |
| Gross Profit | 224K | 324K | 61K | (62K) | 5.52M |
| Gross Margin | 42.9% | 41.2% | 9.5% | -11.9% | 91.7% |
| Research & Development | 5.99M | 4.26M | 2.94M | 3.66M | 3.51M |
| Selling, General & Admin | 12.18M | 10.64M | 9.27M | 10.12M | 23.13M |
| Operating Expenses | 18.37M | 15.84M | 12.49M | 13.84M | 26.64M |
| Depreciation & Amortization | 312K | 255K | 162K | 60K | 680K |
| EBITDA | (17.82M) | (14.5M) | (12.11M) | (13.8M) | (39.58M) |
| EBITDA Margin | -3413.8% | -1842.9% | -1880.0% | -2654.4% | -657.7% |
| Operating Income | (18.14M) | (15.52M) | (12.43M) | (13.9M) | (21.12M) |
| Operating Margin | -3475.5% | -1971.5% | -1929.8% | -2673.7% | -351.0% |
| Interest Income | 0 | 0 | 257K | 0 | 0 |
| Interest Expense | 0 | 834K | 0 | 17K | 635K |
| Other Income / Expenses | 10K | 1.44M | 3.58M | 2.16M | (19.77M) |
| Income Before Tax | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Pre-Tax Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Net Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| EPS (Basic) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| EPS (Diluted) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| Weighted Avg Shares | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
| Weighted Avg Shares (Diluted) | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.